Skip to main content
Japan Lifeline Co., Ltd. logo

Japan Lifeline Co., Ltd. — Investor Relations & Filings

Ticker · 7575 ISIN · JP3754500001 LEI · 353800QUW6LROZVA6765 T Manufacturing
Open in API
Filings indexed 73 across all filing types
Latest filing 2026-05-26 Notice of Dividend Amou…
Country JP Japan
Listing T 7575

About Japan Lifeline Co., Ltd.

https://www.japanlifeline.com/

Japan Lifeline Co., Ltd. is a medical device company specializing in the cardiovascular field. It operates with a hybrid business model, functioning as both a manufacturer of proprietary products and a full-service distributor of advanced medical devices from other global companies. The company's portfolio is focused on treating cardiac diseases, with a strong emphasis on electrophysiology and cardiac rhythm management. Key products include cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), and a range of high-performing cardiac ablation and diagnostic catheters used for treating arrhythmias. The company provides comprehensive solutions and support to medical professionals in the cardiovascular sector.

Recent filings

Filing Released Lang Actions
剰余金の配当に関するお知らせ
Notice of Dividend Amount Classification · 92% confidence The document is a formal announcement by the board of directors regarding the cash dividend per share for the fiscal year ended March 31, 2026, including dividend amount, record date, payment date, total dividend, and rationale. This matches the criteria for a Notice of Dividend Amount (DIV).
2026-05-26 Japanese
商号変更に関するお知らせ
Regulatory Filings Classification · 87% confidence The document is an official corporate announcement notifying shareholders and the market of a planned change in the company’s trade name, including the conditions and planned dates. It does not present financial statements, proxy materials, or dividend details, nor is it an AGM presentation or a stock issuance. It is a general regulatory announcement about corporate matters; thus it falls into the fallback category “Regulatory Filings (RNS).”
2026-05-26 Japanese
定款の一部変更に関するお知らせ
Regulatory Filings Classification · 83% confidence The document is a public announcement of a board resolution to propose partial amendments to the Articles of Incorporation at the upcoming 46th Annual General Meeting, including a corporate name change and governance rule revisions. It is not the full proxy statement nor a financial report, but a regulatory disclosure of agenda items for a shareholder meeting. As it does not fit other specific categories (e.g., no insider trades, no earnings data, no audit, no M&A, no dividend notice), it falls under general regulatory announcements.
2026-05-26 Japanese
2026年３月期決算短信〔日本基準〕（連結）
Regulatory Filings
2026-05-07 Japanese
半期報告書－第46期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Japan Lifeline Co., Ltd. under the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial statements, management analysis (MDA), and business performance data for the interim period (April 1, 2025, to September 30, 2025). This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2026
2025-11-14 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の５の２第１項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification regarding the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. H1 2025
2025-11-14 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.